EA200101232A1 - Соединения феноксипропиламина - Google Patents
Соединения феноксипропиламинаInfo
- Publication number
- EA200101232A1 EA200101232A1 EA200101232A EA200101232A EA200101232A1 EA 200101232 A1 EA200101232 A1 EA 200101232A1 EA 200101232 A EA200101232 A EA 200101232A EA 200101232 A EA200101232 A EA 200101232A EA 200101232 A1 EA200101232 A1 EA 200101232A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- phenoxypropylamine
- compound
- antidepressants
- hydrates
- expressing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Abstract
Данное изобретение относится к соединению феноксипропиламина формулы (I)в которой каждый символ имеет значение, указанное в описании, его оптически активной форме или его фармацевтически приемлемой соли и гидратам, которые одновременно демонстрируют селективное сродство и антагонистическое действие по отношению к 5-HTрецептору, а также действие, ингибирующее повторное поглощение 5-НТ, и может быть использовано в качестве антидепрессантов, быстро оказывающих антидепрессивное действие.Международная заявка была опубликована вместе с отчетом о международном поиске.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14275099 | 1999-05-24 | ||
JP16616099 | 1999-06-14 | ||
JP27738499 | 1999-09-29 | ||
JP2000018080 | 2000-01-25 | ||
PCT/JP2000/003279 WO2000071517A1 (fr) | 1999-05-24 | 2000-05-22 | Compose de phenoxypropylamine |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200101232A1 true EA200101232A1 (ru) | 2002-06-27 |
EA004704B1 EA004704B1 (ru) | 2004-06-24 |
Family
ID=27472476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200101232A EA004704B1 (ru) | 1999-05-24 | 2000-05-22 | Производные феноксипропиламина |
Country Status (17)
Country | Link |
---|---|
US (2) | US6720320B2 (ru) |
EP (1) | EP1188747B1 (ru) |
JP (1) | JP3893878B2 (ru) |
KR (2) | KR100882544B1 (ru) |
CN (1) | CN1164574C (ru) |
AT (1) | ATE303987T1 (ru) |
AU (1) | AU777594B2 (ru) |
BR (1) | BR0011542A (ru) |
CA (2) | CA2716369C (ru) |
DE (1) | DE60022504T2 (ru) |
DK (1) | DK1188747T3 (ru) |
EA (1) | EA004704B1 (ru) |
ES (1) | ES2244438T3 (ru) |
IL (2) | IL146564A0 (ru) |
MX (1) | MXPA01012046A (ru) |
NZ (1) | NZ516111A (ru) |
WO (1) | WO2000071517A1 (ru) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001046177A1 (en) * | 1999-12-20 | 2001-06-28 | Eli Lilly And Company | Benzofuran derivatives |
DE60026581T2 (de) | 1999-12-20 | 2006-12-28 | Eli Lilly And Co., Indianapolis | Indolderivate zur behandlung von depression und angstzuständen |
WO2002042297A1 (fr) * | 2000-11-27 | 2002-05-30 | Mitsubishi Pharma Corporation | Composes de piperidine et son utilisation medicale |
JP2006503846A (ja) * | 2002-09-26 | 2006-02-02 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 精神***病の治療のためのヘテロ環式置換ピペラジン類 |
SE0303280D0 (sv) * | 2003-12-05 | 2003-12-05 | Astrazeneca Ab | Novel compounds |
BRPI0416739A (pt) * | 2003-12-08 | 2007-01-16 | Warner Lambert Co | derivados de indano substituìdo heterocìclico e compostos afins para o tratamento de esquizofrenia |
GB0407025D0 (en) * | 2004-03-29 | 2004-04-28 | Glaxo Group Ltd | Novel compounds |
US7674822B2 (en) | 2004-11-24 | 2010-03-09 | Wyeth | PTP1b inhibitors |
WO2006101454A1 (en) * | 2005-03-21 | 2006-09-28 | S*Bio Pte Ltd | Benzothiophene derivatives: preparation and pharmaceutical applications |
TWI320783B (en) | 2005-04-14 | 2010-02-21 | Otsuka Pharma Co Ltd | Heterocyclic compound |
SI1879573T1 (sl) | 2005-05-10 | 2013-04-30 | Incyte Corporation Experimental Station | Modulatorji indolamin 2,3-dioksigenaze in postopki za uporabo le-te |
AR055203A1 (es) | 2005-08-31 | 2007-08-08 | Otsuka Pharma Co Ltd | Derivados de benzotiofeno con propiedades antipsicoticas |
WO2007065655A1 (en) * | 2005-12-07 | 2007-06-14 | Neurosearch Sweden Ab | Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission |
ES2540561T3 (es) | 2005-12-20 | 2015-07-10 | Incyte Corporation | N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa |
EP1971595B1 (en) * | 2005-12-30 | 2013-10-16 | Merck Sharp & Dohme Corp. | Cetp inhibitors |
US9249407B2 (en) | 2006-02-03 | 2016-02-02 | Opko Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
US7649098B2 (en) * | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
CL2007002650A1 (es) * | 2006-09-19 | 2008-02-08 | Incyte Corp | Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras. |
JP5319532B2 (ja) | 2006-09-19 | 2013-10-16 | インサイト・コーポレイション | インドールアミン2,3−ジオキシゲナーゼのモジュレーターとしてのn−ヒドロキシアミジノヘテロサイクル |
JP2008195654A (ja) * | 2007-02-14 | 2008-08-28 | Mitsubishi Tanabe Pharma Corp | ベンゾ[b]フラン化合物の新規結晶形 |
US20090270496A1 (en) * | 2007-05-03 | 2009-10-29 | Courchesne William E | Antifungal compounds |
TW200920355A (en) * | 2007-09-06 | 2009-05-16 | Lexicon Pharmaceuticals Inc | Compositions and methods for treating immunological and inflammatory diseases and disorders |
IE20070928A1 (en) * | 2007-12-21 | 2009-09-30 | Giuliani Int Ltd | Multi target ligands |
ES2524266T3 (es) | 2008-07-08 | 2014-12-04 | Incyte Corporation | 1,2,5-Oxadiazoles como inhibidores de la indoleamina 2,3-dioxigenasa |
US10316000B2 (en) | 2009-02-18 | 2019-06-11 | Cornell University | Coupled recognition/detection system for in vivo and in vitro use |
US8324250B2 (en) | 2009-03-19 | 2012-12-04 | Hoffmann-La Roche Inc. | Piperidine derivatives as NK3 receptor antagonists |
US8476309B2 (en) * | 2009-08-20 | 2013-07-02 | The University Of Tennessee Research Foundation | Benzofuran cannabinoid compounds and related methods of use |
WO2013016694A2 (en) | 2011-07-27 | 2013-01-31 | Cornell University | Methods for rna detection and quantification |
NZ750189A (en) * | 2013-01-24 | 2020-08-28 | Minerva Neurosciences Inc | Use of phenoxypropylamine compounds to treat depression |
CN105612154A (zh) | 2013-08-07 | 2016-05-25 | 卡迪拉保健有限公司 | 作为詹纳斯激酶的抑制剂的n-氰基甲基酰胺 |
US9664676B2 (en) | 2013-09-06 | 2017-05-30 | Cornell University | RNA sequences that induce fluorescence of small molecule fluorophores |
US20150158926A1 (en) | 2013-10-21 | 2015-06-11 | Opko Biologics, Ltd. | Long-acting polypeptides and methods of producing and administering same |
SG10201803874PA (en) | 2013-11-08 | 2018-07-30 | Incyte Holdings Corp | Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor |
CN107108556B (zh) | 2014-11-03 | 2020-09-29 | 艾欧米制药有限公司 | 药用化合物 |
US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
EP3988113A1 (en) | 2015-06-19 | 2022-04-27 | OPKO Biologics Ltd. | Long-acting coagulation factors and methods of producing same |
ES2964790T3 (es) * | 2016-05-25 | 2024-04-09 | Minerva Neurosciences Inc | (2S)-1-[4-(3,4-Diclorofenil)piperidin-1-il]-3-[2-(5-metil-l,3,4-oxadiazol-2-il)benzo[b]furano-4-iloxi]propan-2-ol o su metabolito para tratar trastornos de ansiedad |
CA3110652A1 (en) | 2018-09-04 | 2020-05-22 | Minerva Neurosciences, Inc. | Methods of using a phenoxypropylamine compound to treat pain |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2042054A1 (de) * | 1970-08-25 | 1972-03-02 | Agfa Gevaert Ag | Photographisches Trockenkopierverfahren |
DE2106577C2 (de) * | 1971-02-11 | 1982-07-08 | Agfa-Gevaert Ag, 5090 Leverkusen | Aufzeichnungsmaterial für das photographische Trockenkopierverfahren und photographisches Verfahren zur Herstellung von Bildern |
JPS4718538U (ru) | 1971-03-31 | 1972-11-01 | ||
DE2337461A1 (de) | 1973-07-24 | 1975-02-06 | Boehringer Mannheim Gmbh | Neue indolderivate und verfahren zu deren herstellung |
JPS5292610A (en) | 1976-01-26 | 1977-08-04 | Canon Kk | Electrostatic printing master |
JPS5290307A (en) | 1976-01-26 | 1977-07-29 | Canon Kk | Thermoodeveloping photoosensitive material for electrostatic printing master |
DE2702919A1 (de) * | 1976-01-26 | 1977-07-28 | Canon Kk | Durch erwaermung entwickelbares, lichtempfindliches aufzeichnungsmaterial |
US4191765A (en) * | 1976-05-25 | 1980-03-04 | Hoechst Aktiengesellschaft | 1-Aryloxy-2-hydroxy-3-aminopropanes |
DE2623314C2 (de) | 1976-05-25 | 1984-08-02 | Hoechst Ag, 6230 Frankfurt | 1-Aryloxy-2-Hydroxy-3-aminopropane, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
WO1980000152A1 (en) * | 1978-07-03 | 1980-02-07 | Sandoz Ag | 3-aminopropoxy-aryl derivates,preparation and use thereof |
JPS55100361A (en) | 1979-01-18 | 1980-07-31 | Sandoz Ag | 33aminopropoxyaryl derivative |
JPS58121214A (ja) * | 1982-01-09 | 1983-07-19 | Kanegafuchi Chem Ind Co Ltd | 血小板凝集阻害剤 |
JPS60202872A (ja) * | 1984-03-27 | 1985-10-14 | Kaken Pharmaceut Co Ltd | ベンゾフラン誘導体、その製法およびそれを有効成分とする降圧剤 |
DE3427985A1 (de) * | 1984-07-28 | 1986-01-30 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue 2h-l-benzopyran-2-on-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten |
JPS6157572A (ja) * | 1984-08-28 | 1986-03-24 | Kanegafuchi Chem Ind Co Ltd | 新規α−ベンジリデン−γ−ブチロラクトン誘導体 |
JPS61218582A (ja) * | 1985-03-23 | 1986-09-29 | Kaken Pharmaceut Co Ltd | ベンゾフラン誘導体、その製法およびそれを有効成分とする降圧剤 |
HU209759B (en) * | 1986-07-17 | 1994-10-28 | Hem Res Inc | Method for the preparation of synergistic pharmaceutical composition containing lymphokines and mismatched double-stranded rnas |
US4861897A (en) * | 1987-06-22 | 1989-08-29 | Ortho Pharmaceutical Corporation | 2-Aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles |
HU209753B (en) | 1990-12-13 | 1995-02-28 | Richter Gedeon Vegyeszeti Gyar Rt. | Process for producing of 3-(4-nitrophenoxy)-propylamine derivatives and pharmaceutical compositions comprising them |
WO1992018089A2 (en) * | 1991-04-09 | 1992-10-29 | The Upjohn Company | Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells |
US5281624A (en) * | 1991-09-27 | 1994-01-25 | Eli Lilly And Company | N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof |
ES2152310T3 (es) | 1993-03-29 | 2001-02-01 | Basf Ag | Derivados de 1-amino-3-fenoxipropano como moduladores de la resistencia a multiples a farmacos. |
US5500431A (en) * | 1993-04-14 | 1996-03-19 | Eli Lilly And Company | Tetrahydro-β-carbolines |
EP0620222A3 (en) | 1993-04-14 | 1995-04-12 | Lilly Co Eli | Tetrahydro-beta-carbolines. |
JPH0717952A (ja) * | 1993-06-29 | 1995-01-20 | Nissan Chem Ind Ltd | ベンジリデン誘導体 |
JPH09510216A (ja) * | 1994-03-11 | 1997-10-14 | イーライ・リリー・アンド・カンパニー | 5−ht▲下2b▼受容体に関連する病態を治療するための方法 |
US5789402A (en) | 1995-01-17 | 1998-08-04 | Eli Lilly Company | Compounds having effects on serotonin-related systems |
US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
JPH09136877A (ja) | 1995-06-16 | 1997-05-27 | Takeda Chem Ind Ltd | 複素環化合物、その製造法及び用途 |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
JP4246822B2 (ja) | 1997-09-26 | 2009-04-02 | 興和株式会社 | テトラゾール誘導体 |
DE69805033T2 (de) * | 1997-09-26 | 2002-11-14 | Kowa Co | Tetrazolderivate als LTD4 und H1 Antagonisten |
JP2002513001A (ja) * | 1998-04-29 | 2002-05-08 | アメリカン・ホーム・プロダクツ・コーポレイション | 抗精神病性のインドリル誘導体 |
JP2000086603A (ja) * | 1998-07-15 | 2000-03-28 | Yoshitomi Pharmaceut Ind Ltd | 桂皮酸アミド誘導体および3―フェニルプロピオン酸アミド誘導体 |
TR200101779T2 (tr) * | 1998-12-18 | 2001-12-21 | Basilea Pharmaceutica Ag | Yeni bisiklik bileşenler |
WO2002042297A1 (fr) * | 2000-11-27 | 2002-05-30 | Mitsubishi Pharma Corporation | Composes de piperidine et son utilisation medicale |
-
2000
- 2000-05-22 DK DK00927844T patent/DK1188747T3/da active
- 2000-05-22 IL IL14656400A patent/IL146564A0/xx not_active IP Right Cessation
- 2000-05-22 CA CA2716369A patent/CA2716369C/en not_active Expired - Lifetime
- 2000-05-22 BR BR0011542-8A patent/BR0011542A/pt not_active IP Right Cessation
- 2000-05-22 AU AU46160/00A patent/AU777594B2/en not_active Ceased
- 2000-05-22 KR KR1020077026625A patent/KR100882544B1/ko active IP Right Grant
- 2000-05-22 EP EP00927844A patent/EP1188747B1/en not_active Expired - Lifetime
- 2000-05-22 MX MXPA01012046A patent/MXPA01012046A/es active IP Right Grant
- 2000-05-22 CA CA2375008A patent/CA2375008C/en not_active Expired - Lifetime
- 2000-05-22 KR KR1020017015024A patent/KR100799134B1/ko active IP Right Grant
- 2000-05-22 JP JP2000619774A patent/JP3893878B2/ja not_active Expired - Lifetime
- 2000-05-22 EA EA200101232A patent/EA004704B1/ru not_active IP Right Cessation
- 2000-05-22 DE DE60022504T patent/DE60022504T2/de not_active Expired - Lifetime
- 2000-05-22 WO PCT/JP2000/003279 patent/WO2000071517A1/ja active IP Right Grant
- 2000-05-22 CN CNB008086044A patent/CN1164574C/zh not_active Expired - Lifetime
- 2000-05-22 AT AT00927844T patent/ATE303987T1/de not_active IP Right Cessation
- 2000-05-22 NZ NZ516111A patent/NZ516111A/en unknown
- 2000-05-22 ES ES00927844T patent/ES2244438T3/es not_active Expired - Lifetime
-
2001
- 2001-11-19 IL IL146564A patent/IL146564A/en unknown
- 2001-11-23 US US09/990,389 patent/US6720320B2/en not_active Expired - Lifetime
-
2003
- 2003-12-22 US US10/740,418 patent/US7196199B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
KR100799134B1 (ko) | 2008-01-29 |
US6720320B2 (en) | 2004-04-13 |
CN1164574C (zh) | 2004-09-01 |
NZ516111A (en) | 2003-05-30 |
CA2375008C (en) | 2011-01-04 |
CA2716369A1 (en) | 2000-11-30 |
ES2244438T3 (es) | 2005-12-16 |
AU777594B2 (en) | 2004-10-21 |
WO2000071517A1 (fr) | 2000-11-30 |
US7196199B2 (en) | 2007-03-27 |
KR20020012235A (ko) | 2002-02-15 |
ATE303987T1 (de) | 2005-09-15 |
IL146564A (en) | 2006-12-31 |
JP3893878B2 (ja) | 2007-03-14 |
EP1188747B1 (en) | 2005-09-07 |
IL146564A0 (en) | 2002-07-25 |
CA2375008A1 (en) | 2000-11-30 |
MXPA01012046A (es) | 2003-09-04 |
EP1188747A1 (en) | 2002-03-20 |
EP1188747A4 (en) | 2002-10-09 |
EA004704B1 (ru) | 2004-06-24 |
DE60022504D1 (de) | 2005-10-13 |
BR0011542A (pt) | 2002-03-05 |
US20020111358A1 (en) | 2002-08-15 |
DK1188747T3 (da) | 2006-01-23 |
CA2716369C (en) | 2013-05-14 |
AU4616000A (en) | 2000-12-12 |
US20040138227A1 (en) | 2004-07-15 |
DE60022504T2 (de) | 2006-06-29 |
KR20070118193A (ko) | 2007-12-13 |
KR100882544B1 (ko) | 2009-02-12 |
CN1378533A (zh) | 2002-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1188747T3 (da) | Phenoxypropylaminforbindelser | |
DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
RS50140B (sr) | Postupak za dobijanje perkihinina i njegova upotreba | |
NO20033385L (no) | Fuserte heterocykliske forbindelser | |
RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
RS53428B (en) | COMPOSITIONS AND ANTI-VIRUS ACTIVITY OF SUBSTITUTED AZAINDOLOXOSCETER PIPERAZINE DERIVATIVES | |
DK1585739T3 (da) | Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer | |
NO20076498L (no) | Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren | |
EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
RS50229B (sr) | Analozi vitamina d3 | |
NO984481D0 (no) | 4-((thien-3-yl)metyl) imidazolderivater med <alfa>-2-adrenoceptor agonistisk aktivitet | |
DE60002583D1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
BR0209901A (pt) | Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina | |
WO2004067703A3 (en) | 5ht7 antagonists and inverse agonists | |
DE60316436D1 (de) | Amidderivate als inhibitoren der enzymatischen aktivität von renin | |
DE50004731D1 (de) | Substituierte benzimidazole, ihre herstellung und ihre verwendung als mittel gegen parasitäre protozoen | |
ATE374751T1 (de) | 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern | |
CO5690574A2 (es) | Nuevos compuestos derivados de indolina como inhibidores de la colesterol-actiltransferasa (acat) y uso medico del mismo | |
ATE448216T1 (de) | Tetralin- und indanderivate und anwendungen davon | |
ATE338046T1 (de) | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza- cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität | |
WO2004099129A3 (en) | Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same | |
DK1409490T3 (da) | 2-(Aminomethyl)tetrahydro-9-oxa-1,3-diazacyclopenta[a]-naphthalenylderivater med antipsykotisk virkning | |
ITVR20020007U1 (it) | Capo d'abbigliamento, particolarmente per karting | |
ATE404548T1 (de) | Cyclisches hemiacetalderivat und dessen anwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |